lentinan has been researched along with Carcinoma, Hepatocellular in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, H; Meng, F; Qu, K; Ren, B; Ren, L; Wang, H; Wang, Z; Yu, W; Zhou, L | 1 |
| Han, X; Li, YD; Wang, Y; Wang, YB; Zhang, DJ; Zhao, SY; Zhao, ZH | 1 |
| Cheng, F; Cheng, Y; Huang, X; Li, Q; Wang, J; Wang, K; Zhang, Y | 1 |
| Liang, M; Shen, B; Yang, P; Zhang, Y | 1 |
| Fukuda, S; Moriya, N; Sakata, Y; Sasaki, D; Suto, T; Watanabe, Y; Yoshida, Y | 1 |
| Abe, Y; Horiuchi, A; Kimura, S; Miyake, M; Miyazaki, T | 1 |
| Hori, Y; Isogawa, S; Nakagawa, S; Saho, M; Takahashi, T; Watanabe, M; Yokoyama, K; Yoshida, H | 1 |
| Hino, K; Hirano, Y; Ideguchi, S; Ohmoto, K; Ohumi, T; Takatori, K; Yamamoto, R; Yamamoto, S | 1 |
| Inagaki, Y; Miyairi, M; Miyamoto, K | 1 |
2 trial(s) available for lentinan and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Combined Modality Therapy; Female; Humans; Lentinan; Liver Neoplasms; Male; Middle Aged; Survival Rate | 2008 |
Clinical study of biological response modifiers as maintenance therapy for hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Embolization, Therapeutic; Ethanol; Female; Fluorouracil; Humans; Immunologic Factors; Lentinan; Liver Neoplasms; Male; Middle Aged; Picibanil; Survival Rate | 1994 |
7 other study(ies) available for lentinan and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Apaf1 nanoLuc biosensors identified lentinan as a potent synergizer of cisplatin in targeting hepatocellular carcinoma cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptotic Protease-Activating Factor 1; Biosensing Techniques; Carcinoma, Hepatocellular; Cisplatin; Drug Synergism; Hep G2 Cells; Humans; Lentinan; Liver Neoplasms; Mutation | 2021 |
Effects of tumor-specific antigen induced by lentinan on murine H22 hepatocellular carcinoma immunoprophylaxis.
Topics: Animals; Antigens, Neoplasm; Cancer Vaccines; Carcinoma, Hepatocellular; Cell Line, Tumor; Female; Immunity, Cellular; Immunization; Lentinan; Liver Neoplasms, Experimental; Lymphocytes; Macrophages; Mice; Phagocytosis; Spleen | 2015 |
Polysaccharide from Lentinus edodes combined with oxaliplatin possesses the synergy and attenuation effect in hepatocellular carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Hepatocellular; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Hep G2 Cells; Humans; Inhibitor of Apoptosis Proteins; Lentinan; Liver Neoplasms; Male; Mice, Inbred BALB C; Mitochondria, Liver; NF-kappa B; Organoplatinum Compounds; Oxaliplatin; Repressor Proteins; Signal Transduction; STAT3 Transcription Factor; Survivin; Transfection; Tumor Burden | 2016 |
The endogenous induction of tumor necrosis factor serum (TNS) for the adjuvant postoperative immunotherapy of cancer--changes in immunological markers of the blood.
Topics: Aged; Antigens, CD; Biomarkers, Tumor; Carcinoma, Hepatocellular; CD4-Positive T-Lymphocytes; Esophageal Neoplasms; Female; Humans; Immunotherapy; Interferons; Lentinan; Leukocyte Count; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Picibanil; Postoperative Period; Remission Induction; Stomach Neoplasms; T-Lymphocytes, Regulatory; Tumor Necrosis Factor-alpha | 1990 |
[A case of hepatocellular carcinoma in an elderly patient that improved upon combination therapy of Lentinan and Tegafur].
Topics: Aged; Aged, 80 and over; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Humans; Lentinan; Liver Neoplasms; Male; Remission Induction; Tegafur | 1990 |
[NK activity and T cell subsets in percutaneous ethanol injection therapy of liver cancer--effect of lentinan with combined use].
Topics: Administration, Cutaneous; Carcinoma, Hepatocellular; Ethanol; Humans; Killer Cells, Natural; Lentinan; Liver Neoplasms; Polysaccharides; T-Lymphocytes | 1989 |
[Successful therapy with tegafur and lentinan after TAE for hepatocellular carcinoma--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Embolization, Therapeutic; Gelatin Sponge, Absorbable; Humans; Iodized Oil; Lentinan; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Polysaccharides; Tegafur | 1989 |